This inventor holds 3 USPTO granted patents, plus 1 CIPO patent and 2 EPO patents. Top assignees: Mogam Institute for Biomedical Research, The Green Cross Corporation. Active years: 2019-2020.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
3 out of 17 
1 out of 264 
Years Active: 2019-2020
Title: The Innovative Contributions of Kisu Kim in Cancer Research
Introduction
Kisu Kim is a prominent inventor located in Yongin-si, South Korea, known for her significant contributions to cancer research through her innovative patents. With a total of three granted patents, she has been instrumental in developing targeted therapies aimed at improving the diagnosis and treatment of cancer.
Latest Patents
Kisu Kim's latest patents showcase her expertise in the field of oncology. One notable invention is the "Anti-mesothelin antibody and composition comprising the same." This invention involves an antibody that specifically binds to mesothelin (MSLN), a nucleic acid encoding the antibody, and the related pharmaceutical compositions for treating cancer or tumor conditions. The antibody demonstrates high affinity and specificity, making it a potential candidate for effective cancer treatment and diagnosis.
Another significant patent is the "Anti-glypican 3 antibody and pharmaceutical composition containing the same." This invention focuses on an antibody that specifically binds to glypican 3 (GPC3). It includes the nucleic acid encoding the antibody and a method for its production. The pharmaceutical composition derived from this antibody aims to treat cancers, particularly hepatocellular carcinoma, resulting from its high affinity and specificity to glypican 3.
Career Highlights
Throughout her career, Kisu Kim has held important positions at reputable organizations. She has worked with the Mogam Institute for Biomedical Research, where she contributed to groundbreaking biomedical advancements, and The Green Cross Corporation, a company recognized for its innovative approaches in healthcare solutions.
Collaborations
Kisu Kim has collaborated with talented coworkers, including Dong-Sik Kim and Hyung-Kwon Lim. Together, they have shared their expertise to drive forward innovations in the field of cancer research, further enhancing the development of novel therapeutic options.
Conclusion
Kisu Kim's innovative work and patents in the realm of antibodies targeting specific cancer antigens represent her dedication to improving cancer treatment strategies. Her collaborations with other professionals in the industry highlight the importance of teamwork in advancing medical research. As she continues to push the boundaries of innovation, Kisu Kim remains a pivotal figure in the fight against cancer.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile